Number of parity and the risk of gallbladder cancer: a systematic review and dose–response meta-analysis of observational studies

Archives of Gynecology and Obstetrics

Volumn 293, Issue 5, 2016, Pages 1087-1096

  Guo, Peng ^a   Xu, Chang ^b   Zhou, Quan ^c   Zhou, JianGuo ^a   Zhao, JuanJuan ^a   Si, ZhuangLi ^a   Shen, Cheng ^d   Feng, ChunLin ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c The First People's Hospital of Changde City   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

Dose response meta analysis; Gallbladder cancer; Parity; Risk factor; Systematic review

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; GALLBLADDER CANCER; HIGH RISK POPULATION; HUMAN; NULLIPARA; PARITY; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; FEMALE; GALLBLADDER NEOPLASMS; META ANALYSIS; OBSERVATIONAL STUDY; PREGNANCY; RISK FACTOR;

FEMALE; GALLBLADDER NEOPLASMS; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PARITY; PREGNANCY; RISK ASSESSMENT; RISK FACTORS;

EID: 84944590679     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3896-6     Document Type: Article

References (61)

1. Rakic M, Patrlj L, Kopljar M, Klicek R, Kolovrat M, Loncar B, Busic Z (2014) Gallbladder cancer. Hepatobiliary Surg Nutr 3(5):221–226. doi:10.3978/j.issn.2304-3881.2014.09.03
2. Saika K, Machii R (2014) Five-year relative survival rate of gallbladder cancer in the USA, Europe and Japan. Jpn J Clin Oncol 44(7):704. doi:10.1093/jjco/hyu087
3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. doi:10.3322/caac.21262
4. Hundal R, Shaffer EA (2014) Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 6:99–109. doi:10.2147/clep.s37357
5. Zhu AX, Hong TS, Hezel AF, Kooby DA (2010) Current management of gallbladder carcinoma. Oncologist 15(2):168–181. doi:10.1634/theoncologist.2009-0302
6. Sakata J, Takizawa K, Takano K, Kobayashi T, Minagawa M, Wakai T (2014) Current surgical treatment for gallbladder cancer. Nihon Geka Gakkai zasshi 115(4):185–189
7. Chan T-F, Wu C-H, Chiu H-F, Yang C-Y (2015) Parity and risk of death from gallbladder cancer among a cohort of premenopausal parous women in Taiwan. Int J Environ Res Public Health 12(2):1864–1873. doi:10.3390/ijerph120201864
8. Andreotti G, Hou L, Gao YT, Brinton LA, Rashid A, Chen J, Shen MC, Wang BS, Han TQ, Zhang BH, Sakoda LC, Fraumeni JF Jr, Hsing AW (2010) Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China. Br J Cancer 102(7):1185–1189. doi:10.1038/sj.bjc.6605597
9. Kilander C, Mattsson F, Lu Y, Ljung R, Lagergren J, Sadr-Azodi O (2015) Reproductive factors and risk of biliary tract cancer in a population-based study. Acta Oncol (Stockholm, Sweden). doi:10.3109/0284186x.2015.1016627
10. Lambe M, Trichopoulos D, Hsieh CC, Ekbom A, Adami HO, Pavia M (1993) Parity and cancers of the gall bladder and the extrahepatic bile ducts. Int J Cancer J Int du Cancer 54(6):941–944
11. Moerman CJ, Berns MP, Bueno de Mesquita HB, Runia S (1994) Reproductive history and cancer of the biliary tract in women. Int J Cancer J Int du Cancer 57(2):146–153
12. Pandey M, Shukla VK (2003) Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev 12(4):269–272. doi:10.1097/01.cej.0000082604.47188.5d
13. Nakadaira H, Lang I, Szentirmay Z, Hitre E, Kaster M, Yamamoto M (2009) A case–control study of gallbladder cancer in Hungary. Asian Pac J Cancer Prev APJCP 10(5):833–836
14. Strom BL, Soloway RD, Rios-Dalenz JL, Rodriguez-Martinez HA, West SL, Kinman JL, Polansky M, Berlin JA (1995) Risk factors for gallbladder cancer. An international collaborative case–control study. Cancer 76(10):1747–1756
15. Grodstein F, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ (1994) A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynecol 84(2):207–214
16. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clin Res ed) 339:b2535. doi:10.1136/bmj.b2535
17. Xu C, Zeng XT, Liu TZ, Zhang C, Yang ZH, Li S, Chen XY (2015) Fruits and vegetables intake and risk of bladder cancer: A PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies. Med (Baltimore) 94(17):e759. doi:10.1097/md.0000000000000759
18. Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, Jain M, Przewozniak K, Baghurst P, Moerman CJ, Simard A, Howe GR, McMichael AJ, Hsieh CC, Walker AM (1997) Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 89(15):1132–1138
19. Shukla VK, Chauhan VS, Mishra RN, Basu S (2008) Lifestyle, reproductive factors and risk of gallbladder cancer. Singapore Med J 49(11):912–915
20. Panda D, Sharma A, Shukla NK, Jaiswal R, Dwivedi S, Raina V, Mohanti BK, Deo SV, Patra S (2013) Gall bladder cancer and the role of dietary and lifestyle factors: a case-control study in a north Indian population. Eur J Cancer Prev 22(5):431–437. doi:10.1097/CEJ.0b013e32835f3b45
21. Alvi AR, Siddiqui NA, Zafar H (2011) Risk factors of gallbladder cancer in Karachi—a case-control study. World J Surg Oncol 9:164. doi:10.1186/1477-7819-9-164
22. Kumar JR, Tewari M, Rai A, Sinha R, Mohapatra SC, Shukla HS (2006) An objective assessment of demography of gallbladder cancer. J Surg Oncol 93(8):610–614
23. Jain K, Sreenivas V, Velpandian T, Kapil U, Garg PK (2013) Risk factors for gallbladder cancer: a case-control study. Int J Cancer 132(7):1660–1666. doi:10.1002/ijc.27777
24. Hsing AW (2012) Lifestyle, infection, and genetic factors in relation to biliary tract cancer. Cancer Prev Res 5(11). doi:10.1158/1940-6207.PREV-12-CN05-03
25. Beral V (1983) Parity and susceptibility to cancer. Ciba Found Symp 96:182–203
26. de Aretxabala X, Riedeman P, Burgos L, Roa I, Araya JC, Echeverria X, Toledo MI, Charles M, Espinoza O, Wenzel C (1995) Gallbladder cancer. case-control study. Rev Med Chil 123(5):581–586
27. Dwivedi S, Madeshiya A, Singh D, Singh S, Krishna A (2013) Gall bladder cancer and some epidemiological factors: a cross sectional study. Biomed Res India 24(1):83–87
28. Moerman CJ, Bueno-De-Mesquita HB (1999) The epidemiology of gallbladder cancer: lifestyle related risk factors and limited surgical possibilities for prevention. Hepatogastroenterology 46(27):1533–1539
29. Zhang XH, Gao YT, Rashid A, Deng J, Cheng JR, Liu EJ, Wu K, Sun L, Gridley G, Hsing AW (2005) Number of pregnancies and risk of gallbladder cancer: a population-based case-control study in Shanghai. Tumor 25(2):148–151
30. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 1 Sep 2015
31. Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L (2015) The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 8(1):2–10. doi:10.1111/jebm.12141
32. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309
33. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1):66–73. doi:10.1093/aje/kwr265
34. Orsini N (2013) Multivariate dose-response meta-analysis: an update on glst. Available at: http://www.stata.com/meeting/nordic-and-baltic13/abstracts. Accessed May 2015
35. Orsini N, Bellocco R, Greenland S (2005) Generalized least squares for trend estimation of summarized dose-response data. Stata J 6(1):40–57
36. Jackson D, White IR, Thompson SG (2010) Extending DerSimonian and Laird’s methodology to perform multivariate random effects meta-analyses. Stat Med 29(12):1282–1297. doi:10.1002/sim.3602
37. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
38. Orsini N (2011) A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J 11(1):1–29
39. Hedges LV, Pigott TD (2001) The power of statistical tests in meta-analysis. Psychol Methods 6(3):203–217
40. Cafri G, Kromrey JD, Brannick MT (2009) A SAS macro for statistical power calculations in meta-analysis. Behav Res Methods 41(1):35–46. doi:10.3758/brm.41.1.35
41. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res ed) 327(7414):557–560. doi:10.1136/bmj.327.7414.557
42. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Res ed) 315(7109):629–634
43. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101
44. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2007) Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med 26(25):4544–4562. doi:10.1002/sim.2889
45. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC (1989) Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 321(9):563–569. doi:10.1056/nejm198908313210902
46. Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, Zheng H, Lauwers GY, Ferrone CR (2009) Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Archiv Surg (Chicago, Ill: 1960) 144 (5):441–447 (discussion 447). doi:10.1001/archsurg.2009.46
47. Schuler S, Ponnath M, Engel J, Ortmann O (2013) Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet 287(6):1187–1204. doi:10.1007/s00404-013-2784-1
48. Singletary BK, Van Thiel DH, Eagon PK (1986) Estrogen and progesterone receptors in human gallbladder. Hepatology 6(4):574–578
49. Baskaran V, Vij U, Sahni P, Tandon RK, Nundy S (2005) Do the progesterone receptors have a role to play in gallbladder cancer? Int J Gastrointestinal cancer 35(1):61–68. doi:10.1385/ijgc:35:1:061
50. Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S (2012) Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res GCR 5(2):41–47
51. Gabbi C, Kim HJ, Barros R, Korach-Andre M, Warner M, Gustafsson JA (2010) Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice. Proc Natl Acad Sci USA 107(33):14763–14768. doi:10.1073/pnas.1009483107
52. Chen A, Huminer D (1991) The role of estrogen receptors in the development of gallstones and gallbladder cancer. Med Hypotheses 36(3):259–260
53. Blum A, Tatour I, Monir M, Khazim K, Simsolo C (2005) Gallstones in pregnancy and their complications: postpartum acute pancreatitis and acute peritonitis. Eur J Intern Med 16(7):473–476. doi:10.1016/j.ejim.2005.03.005
54. Everson GT, McKinley C, Lawson M, Johnson M, Kern F Jr (1982) Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology 82(4):711–719
55. Bertran E, Heise K, Andia ME, Ferreccio C (2010) Gallbladder cancer: incidence and survival in a high-risk area of Chile. Int J Cancer 127(10):2446–2454. doi:10.1002/ijc.25421
56. Borena W, Edlinger M, Bjorge T, Haggstrom C, Lindkvist B, Nagel G, Engeland A, Stocks T, Strohmaier S, Manjer J, Selmer R, Tretli S, Concin H, Hallmans G, Jonsson H, Stattin P, Ulmer H (2014) A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS ONE 9(2):e89368. doi:10.1371/journal.pone.0089368
57. Wenbin D, Zhuo C, Zhibing M, Chen Z, Ruifan Y, Jie J, Cheng Q, Zhenming G (2013) The effect of smoking on the risk of gallbladder cancer: a meta-analysis of observational studies. Eur J Gastroenterol Hepatol 25(3):373–379. doi:10.1097/MEG.0b013e32835a870b
58. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ (Clin Res ed) 350:g7607. doi:10.1136/bmj.g7607
59. Ozasa K (2007) Alcohol use and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pacific J Cancer Prev APJCP 8(Suppl):81–88
60. Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. Available from www.cochrane-handbook.org
61. Zhou Q, Li H, Zhou JG, Ma Y, Wu T, Ma H (2015) Green tea, black tea consumption and risk of endometrial cancer: a systematic review and meta-analysis. Arch Gynecol Obstet. doi:10.1007/s00404-015-3811-1